{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T19:18:55Z","timestamp":1717787935676},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,8,15]]},"DOI":"10.2169\/internalmedicine.8866-21","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T22:08:21Z","timestamp":1643666901000},"page":"2471-2475","source":"Crossref","is-referenced-by-count":4,"title":["Primary Sclerosing Cholangitis and Autoimmune Hepatitis Overlapping Syndrome Complicated by Ulcerative Colitis"],"prefix":"10.2169","volume":"61","author":[{"given":"Takanori","family":"Suzuki","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itaru","family":"Naitoh","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahito","family":"Katano","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Matsuura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihito","family":"Nagura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Nojiri","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Kataoka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Czaja AJ, Manns MP. Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis. Gastroenterology 139: 58-72.e4, 2010.","DOI":"10.1053\/j.gastro.2010.04.053"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Lazaridis KN, LaRusso NF. Primary sclerosing cholangitis. N Engl J Med 375: 1161-1170, 2016.","DOI":"10.1056\/NEJMra1506330"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Takiguchi J, Ohira H, Rai T, et al. Autoimmune hepatitis overlapping with primary sclerosing cholangitis. Intern Med 41: 696-700, 2002.","DOI":"10.2169\/internalmedicine.41.696"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Igarashi G, Endo T, Mikami K, et al. Two cases of primary sclerosing cholangitis overlapping with autoimmune hepatitis in adults. Intern Med 56: 509-515, 2017.","DOI":"10.2169\/internalmedicine.56.7633"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Nakazawa T, Notohara K, Tazuma S, et al. The 2016 diagnostic criteria for primary sclerosing cholangitis. J Gastroenterol 52: 838-844, 2017.","DOI":"10.1007\/s00535-016-1286-x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 317: 1625-1629, 1987.","DOI":"10.1056\/NEJM198712243172603"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Alvarez F, Berg PA, Bianchi FB, et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31: 929-938, 1999.","DOI":"10.1016\/S0168-8278(99)80297-9"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kakuta Y, Naito T, Onodera M, et al. NUDT15 R139C causes thiopurine-induced early severe hair loss and leukopenia in Japanese patients with IBD. Pharmacogenomics J 16: 280-285, 2016.","DOI":"10.1038\/tpj.2015.43"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Chapman R, Fevery J, Kalloo A, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology 51: 660-678, 2010.","DOI":"10.1002\/hep.23294"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. European Association for the Study of the Liver. EASL clinical practice guidelines. Autoimmune hepatitis. J Hepatol 63: 971-1004, 2015.","DOI":"10.1016\/j.jhep.2015.06.030"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Manns MP, Czaja AJ, Gorham JD, et al. Diagnosis and management of autoimmune hepatitis. Hepatology 51: 2193-2213, 2010.","DOI":"10.1002\/hep.23584"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Rodrigues AT, Liu PM, Fagundes ED, et al. Clinical characteristics and prognosis in children and adolescents with autoimmune hepatitis and overlap syndrome. J Pediatr Gastroenterol Nutr 63: 76-81, 2016.","DOI":"10.1097\/MPG.0000000000001125"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Floreani A, Rizzotto ER, Ferrara F, et al. Clinical course and outcome of autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome. Am J Gastroenterol 100: 1516-1522, 2005.","DOI":"10.1111\/j.1572-0241.2005.41841.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Umetsu S, Notohara K, Nakazawa T, et al. Long-term outcomes of pediatric-onset primary sclerosing cholangitis: a single-center experience in Japan. Hepatol Res 49: 1386-1397, 2019.","DOI":"10.1111\/hepr.13421"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Al-Chalabi T, Portmann BC, Bernal W, McFarlane IG, Heneghan MA. Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival. Aliment Pharmacol Ther 28: 209-220, 2008.","DOI":"10.1111\/j.1365-2036.2008.03722.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. L\u00fcth S, Kanzler S, Frenzel C, et al. Characteristics and long-term prognosis of the autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome. J Clin Gastroenterol 43: 75-80, 2009.","DOI":"10.1097\/MCG.0b013e318157c614"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. McNair AN, Moloney M, Portmann BC, Williams R, McFarlane IG. Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases. Am J Gastroenterol 93: 777-784, 1998.","DOI":"10.1111\/j.1572-0241.1998.224_a.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Fukuda K, Kogita S, Tsuchimoto Y, et al. Overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis complicated with hepatocellular carcinoma. Clin J Gastroenterol 5: 183-188, 2012.","DOI":"10.1007\/s12328-012-0294-5"},{"key":"19","unstructured":"19. Nakajima H, Munakata A, Yoshida Y. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine. J Gastroenterol 30 Suppl 8: 115-117, 1995."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Yokokawa J, Kanno Y, Saito H, et al. Risk factors associated with relapse of type 1 autoimmune hepatitis in Japan. Hepatol Res 41: 641-646, 2011.","DOI":"10.1111\/j.1872-034X.2011.00812.x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/16\/61_8866-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T03:18:14Z","timestamp":1660965494000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/16\/61_8866-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,15]]},"references-count":20,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8866-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,15]]},"article-number":"8866-21"}}